Valiant Co.,Ltd (SHE:002643)
China · Delayed Price · Currency is CNY 13.11
+0.22 (1.71%)
Sep 10, 2026, 3:04 PM CST
Valiant Co.,Ltd Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,830 | 3,717 | 3,693 | 4,305 | 5,080 | 4,359 |
Revenue Growth | 6.19% | 0.63% | -14.22% | -15.26% | 16.56% | 49.36% |
Gross Profit Gross Profit Growth | 1,376 | 1,388 | 1,360 | 1,772 | 1,849 | 1,524 |
Operating Income Operating Income Growth | 383.42 | 412.18 | 395.76 | 886.95 | 863.9 | 760.97 |
Net Income Net Income Growth | 243.75 | 284.48 | 246.28 | 763.01 | 721.33 | 626.66 |
Earnings Per Share EPS Growth | 0.27 | 0.31 | 0.26 | 0.84 | 0.79 | 0.69 |
EPS Growth | 2.46% | 19.23% | -69.05% | 6.33% | 14.49% | 23.21% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Functional Materials Functional Materials Growth | 2,912 | 3,019 | 3,366 | 2,999 | 2,749 |
Life Sciences and Pharmaceutical Products Life Sciences and Pharmaceutical Products Growth | 748.02 | 629.08 | 881.68 | 2,035 | 1,572 |
Unallocated Other Operating Income Unallocated Other Operating Income Growth | 57.05 | 44.98 | 57.58 | 47.01 | 37.37 |
Total Total Growth | 3,717 | 3,693 | 4,305 | 5,080 | 4,359 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,464 | 1,218 | 1,235 | 1,255 | 1,187 | 1,354 |
Total Debt Total Debt Growth | 2,079 | 1,712 | 1,752 | 1,374 | 837.79 | 712.24 |
Net Cash (Debt) Net Cash Growth | -614.16 | -494.04 | -516.55 | -119.84 | 349.18 | 641.41 |
Net Cash Growth | - | - | - | - | -45.56% | 23.54% |
Net Cash Per Share Net Cash Per Share Growth | -0.67 | -0.54 | -0.55 | -0.13 | 0.38 | 0.71 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 872.54 | 1,090 | 1,096 | 1,084 | 983 | 1,045 |
Capital Expenditures CapEx Growth | -624 | -693.52 | -1,108 | -1,396 | -1,295 | -731.52 |
Free Cash Flow Free Cash Flow Growth | 248.54 | 396.37 | -12.16 | -311.9 | -311.99 | 313.21 |
Free Cash Flow Growth | 159.41% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 35.94% | 37.33% | 36.84% | 41.16% | 36.40% | 34.97% |
Operating Margin | 10.01% | 11.09% | 10.72% | 20.60% | 17.00% | 17.46% |
Pretax Margin | 9.09% | 10.61% | 11.25% | 22.09% | 18.71% | 17.60% |
Profit Margin | 6.36% | 7.65% | 6.67% | 17.72% | 14.20% | 14.38% |
FCF Margin | 6.49% | 10.66% | -0.33% | -7.25% | -6.14% | 7.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.125 | 0.125 | 0.100 | 0.300 | 0.295 | 0.255 |
Dividend Per Share Growth | 25.00% | 25.00% | -66.67% | 1.70% | 15.69% | 24.39% |
Dividend Yield | 0.99% | 0.84% | 0.85% | 1.89% | 2.14% | 1.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 48.96 | 48.49 | 45.32 | 20.22 | 18.90 | 35.10 |
Forward PE | 25.76 | 24.37 | 18.80 | 16.42 | 13.84 | 26.75 |
P/FCF Ratio | 48.31 | 34.80 | - | - | - | 70.22 |
PS Ratio | 3.14 | 3.71 | 3.02 | 3.58 | 2.68 | 5.05 |